Contract 75A50120D00002
Sanofi Vaccines Us Inc. · Department Of Health And Human Services · September 25, 2020
Sanofi Vaccines Us Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 25, 2020 for $134.74 million of work in biological product (except diagnostic) manufacturing. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 3, 2025. If all options are exercised, the contract could reach $6.34 billion.
Contract details
- PIID
- 75A50120D00002
- Award type
- —
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- First action
- September 25, 2020
- Latest action
- December 3, 2025
Description
THE PURPOSE OF THIS MODIFICATION IS TO: 1) REVISE THE ATTACHMENT 0001 - INCENTIVE FEE MILESTONE SCHEDULE FOR CLINS 0002 AND 0004 PER EMAIL DATED APRIL 28, 2025. 2) FOR CLIN 0002, $2,448,280.30 HAS BEEN PAID TO DATE FOR THE INCENTIVE FEE OUT
Modification timeline
-
December 3, 2025Mod P00017 · Other Administrative Action$612.23M
-
September 24, 2025Mod P00016 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO: 1) ADD FUNDING IN THE AMOUNT OF $44,000,000.00 TO CLIN 0003 DEVELOPMENT - PRE-CLINICAL & CLINICAL PHASES 1 AND 2 TO CHANGE CLINICAL DEVELOPMENT OF RECOMBINANT …$612.23M
-
September 26, 2022Mod P00012 · Other Administrative ActionINCORPORATE TRAVEL LANGUAGE INTO SECTION B.5, ADVANCED UNDERSTANDINGS$568.23M
-
September 29, 2021Mod P00008 · Exercise An OptionDEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES$568.23M
-
September 25, 2020Mod P00003 · Funding Only ActionDEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES$568.23M
-
September 25, 2020Mod P00002 · Other Administrative ActionDEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES$568.23M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120D00002?
Contract 75A50120D00002 is a federal contract awarded to Sanofi Vaccines Us Inc. by Department Of Health And Human Services on September 25, 2020 for $134.74 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 75A50120D00002?
Sanofi Vaccines Us Inc. won contract 75A50120D00002 from Department Of Health And Human Services.
How much is contract 75A50120D00002 worth?
Contract 75A50120D00002 has obligated $134.74 million to date, with a total potential value of $6.34 billion if all options are exercised.